Low Frequency of Treatment of Osteoporosis Among Postmenopausal Women Following a Fracture
Authors:
- Sumit R. MajumdarSMSumit R. Majumdar
- K. Arnold ChanKCK. Arnold Chan
- Diana S. M. BuistDBDiana S. M. Buist
- Alan S. GoAGAlan S. Go
- Michael GoodmanMGMichael Goodman
- David H. SmithDSDavid H. Smith
- Richard PlattRPRichard Platt
- Jerry H. GurwitzJGJerry H. Gurwitz
Open Access
- 22 September 2003
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 163 (17) , 2052-2057
Abstract
OSTEOPOROSIS IS a chronic and progressive condition that leads to decreased bone mass and skeletal fragility; in turn, these conditions can lead to fractures, disability, pain, deformity, and even death.1-5 It is estimated that at least 10 million Americans, including 25% of all women older than 50 years, have osteoporosis.1,3 The lifetime risk of a typical osteoporotic fracture (ie, of the wrist, hip, or vertebra) is about 40%.1-4 The annual cost of treating osteoporosis and its sequelae in the United States has been estimated at $13.8 billion,1,3-5 compared with $7.5 billion for congestive heart failure or $6.2 billion for asthma.6Keywords
This publication has 2 references indexed in Scilit: